戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ociated pneumonia (52%); 7% of patients were bacteremic.
2 lpha, despite the fact that the animals were bacteremic.
3 in the large subcohort whose infections were bacteremic.
4           Fourteen of 48 (29%) patients were bacteremic.
5 r, 4/12 (33%) of the diabetic rabbits became bacteremic.
6 tently Bartonella koehlerae seroreactive and bacteremic.
7                             All animals were bacteremic 1 hr after challenge (mean 3.6 x 10(5) colony
8                      None of the cats became bacteremic after secondary challenge, and all had higher
9 s were hospitalization for pneumococcal CAP (bacteremic and nonbacteremic cases) and all-cause CAP.
10                                         Both bacteremic and nonbacteremic pneumonia seasonality peake
11 pecimens, 31 (93.9%) were judged to be truly bacteremic and/or candidemic based on a medical chart re
12 R-ESI-MS were judged to be truly or possibly bacteremic and/or candidemic, respectively.
13 ive in preventing vaccine-type pneumococcal, bacteremic, and nonbacteremic community-acquired pneumon
14  necrosis at the site of inoculation, became bacteremic, and subsequently died.
15 began receiving ciprofloxacin after becoming bacteremic, and treatment was continued for 10 days.
16 soft tissue, n = 2); 4/8 (50%) patients were bacteremic; and 7/8 (88%) patients with S. maltophilia i
17 ted blood following acquisition feeding on a bacteremic animal host.
18      Meningitis was detected in 20 to 50% of bacteremic animals, and mortality invariably followed ba
19 ysis that involved participants who remained bacteremic at the time of enrollment, we found a median
20                 Patients with infection from bacteremic Bartonella spp., tested using Bartonella Alph
21                         All septic mice were bacteremic, but no differences in bacterial load were id
22 remic by day 7, and all nine cats had become bacteremic by 14 days postinfection.
23         All B. henselae-inoculated cats were bacteremic by 2 weeks after infection.
24                      Seven of nine cats were bacteremic by day 7, and all nine cats had become bacter
25 monly used vasopressor, norepinephrine, in a bacteremic canine model of Pseudomonas aeruginosa sepsis
26                           When combined with bacteremic CAP cases, the proportion of pneumonias with
27 on, 36.4% catheter-related infections, 57.1% bacteremic catheter-related infections).
28 s (1.5%, 2.09/1,000 catheter-days) presented bacteremic catheter-related infections.
29 ts, no conclusion could be reached regarding bacteremic catheter-related infections.
30                       Cat fleas removed from bacteremic cattery cats transmitted B. henselae to five
31 ins could not be explained by differences in bacteremic clearance or initial adherence to sterile veg
32                   Six (19%) of 31 Bartonella bacteremic coyotes exhibited the strain profile that was
33           By PFGE analysis, three Bartonella bacteremic coyotes were infected by a strain identical t
34                                 The other 25 bacteremic coyotes were infected with a strain that was
35 s penetrate the epithelial barrier and cause bacteremic disease or spread within the respiratory trac
36  therapy and duration of therapy in selected bacteremic disease, such as dental bacteremias and bacte
37 score at admission and among persons who had bacteremic disease.
38                      Survival, predictors of bacteremic disseminated tuberculosis, and predictors of
39  total lymphocyte count were associated with bacteremic disseminated tuberculosis.
40 mprovement in bacterial clearance, decreased bacteremic dissemination, and attenuated lung damage.
41 ia in lungs, which correlated with increased bacteremic dissemination.
42 NALT) plus cervical lymphadenopathy prior to bacteremic dissemination.
43                     Organs transplanted from bacteremic donors do not transmit bacterial infection or
44                         There were 95 (5.1%) bacteremic donors from a total of 1775, from whom 212 re
45                       Forty-six (48%) of the bacteremic donors had pathogens in their blood.
46 tient survival for recipients of organs from bacteremic donors was not significantly different from r
47 with those for recipients of organs from non-bacteremic donors.
48 -associated pneumonia were more likely to be bacteremic during their ICU stay (36 [28%] vs. 22 [3%];
49  subclone (ST131-H30) responsible for 28% of bacteremic E. coli infections over a 3-yr period.
50 isolates, all belonging to uropathogenic and bacteremic E. coli strains previously defined as clonal
51 nts were seen with the use of MAB-T88 in the bacteremic enterobacterial common antigen group (p <.05)
52                                            A bacteremic episode was defined as two positive blood cul
53                                              Bacteremic episodes in patients at St Jude Children's Re
54 xperience with this procedure, we noted that bacteremic episodes tended to occur simultaneously with
55                 Positive BC results from 292 bacteremic episodes were reviewed.
56                          Significantly fewer bacteremic episodes with Gram-negative organisms occurre
57                                       Of 830 bacteremic episodes, 188 (77%) of 245 historical and 308
58                                       Of 830 bacteremic episodes, 188 of 245 (77%) historical and 308
59 b cell expansion, diminished the severity of bacteremic episodes, and led to the eventual resolution
60 witch recombination efficiently resolved all bacteremic episodes.
61 tibody responses are required to resolve the bacteremic episodes.
62 aluated by removing fleas from the naturally bacteremic, flea-infested cattery cats and transferring
63                             In patients with bacteremic HAP, telavancin resulted in clearance of bloo
64                                     Of 2,139 bacteremic hospitalized patients, 592 (28%) received sta
65 io, 7.1; P<0.05), a type often implicated in bacteremic human cases.
66 idal Salmonella (iNTS) disease causes severe bacteremic illness among adults with human immunodeficie
67 ogy, diagnosis, prevention, and treatment of bacteremic illness in children.
68 lture is the current standard for diagnosing bacteremic illnesses, yet it is not clear how physicians
69 e-confirmed S. Typhi and controls with other bacteremic illnesses.
70                   Most pathogens in febrile, bacteremic infants 90 days of age or younger hospitalize
71                     Out of 1928 cases of GAS bacteremic infection, 278 were caused by emm89 GAS.
72 heters, which are the most frequent foci for bacteremic infection.
73                                         COSA bacteremic infections are as common as those due to pneu
74 ion were used to compare differences between bacteremic infections due to emm89 GAS belonging to diff
75 tro susceptibility and a propensity to cause bacteremic infections in patients with CF.
76 ed from hospitalized patients with invasive, bacteremic infections may not be the same as those obser
77 utcome were polymicrobial, inflammatory, and bacteremic infections requiring more than 1 debridement,
78 edical condition." Overall, 48% of S. aureus bacteremic infections were COSA (incidence, 17 cases/100
79  by which B. henselae establishes persistent bacteremic infections within cats.
80                             Two patients had bacteremic infections, 4 had abdominal infections withou
81  primarily blood borne (86%), made up 21% of bacteremic infections, and had a recurrent incidence of
82 epidemiological characteristics of emm89 GAS bacteremic infections, including 7-day and 30-day case-f
83 A single-center, quasi-experimental study of bacteremic inpatients before and after AXDX implementati
84 le-center, quasi-experimental study of adult bacteremic inpatients before/after AXDX implementation w
85                              Among 3 907 204 bacteremic inpatients, 1793 (0.05%) were found to have B
86 ransplantation of organs from donors who are bacteremic is controversial.
87 sion of type 3 secretion system exotoxins in bacteremic isolates of P. aeruginosa confers poor clinic
88                                       Of the bacteremic isolates, all but one isolate, drawn from a p
89 susceptibility testing were performed on 499 bacteremic isolates.
90 ever, control SPF kittens housed with highly bacteremic kittens in the absence of fleas did not becom
91 ty-day mortality among the 104 patients with bacteremic KPC-Kp infections was significantly lower tha
92 nal PCV13 serotypes are more likely to cause bacteremic LRTI and empyema in healthy vaccinated childr
93                          Thus, gram-negative bacteremic lung infection and secondary alveolar H/R upr
94 ipheral blood leukocytes (PBL) circulated in bacteremic mice and could establish organ infection in v
95                                The rescue of bacteremic mice could be effected only by phage strains
96 w lin(-)c-kit(+)Sca-1(+) cells isolated from bacteremic mice showed an increase in CFU-granulocyte/ma
97          The ability of this phage to rescue bacteremic mice was demonstrated to be due to the functi
98 sed AM apoptosis and increased the number of bacteremic mice, indicating a novel role for caspase act
99                     In our studies involving bacteremic mice, the problem of the narrow host range of
100 ar type 3 strain in diluted whole blood from bacteremic mice.
101 to monitor the blood-borne stage in a murine bacteremic model of P. aeruginosa infection.
102 pared with that of the wild-type strain in a bacteremic mouse model.
103 entional antibiotics typically used to treat bacteremic newborns (ampicillin and gentamicin).
104                 Although most animals became bacteremic, only those with a severe systemic inflammati
105     We calculated rates of transmission from bacteremic or fungemic donors to their recipients and co
106  carefully inspect the PVC insertion site in bacteremic or fungemic patients, and remove PVCs associa
107 ted on the basis of the patients having been bacteremic or having received vancomycin as the definiti
108 ted from hospital-based patients with either bacteremic or nonbacteremic infections.
109 he multicenter cohort) and (2) isolates from bacteremic or nonbacteremic patients with pneumonia (PP)
110     Between 1986 and 1995, two thirds of all bacteremic organisms were cultured from intravascular ca
111                                              Bacteremic patient sera (n = 32) exhibited IgG antibody
112                      A prospective cohort of bacteremic patient sera exhibited anti-BPI IgG responses
113 sion tree to determine the likelihood that a bacteremic patient was infected with an ESBL producer.
114 phylococcus aureus isolates recovered from a bacteremic patient were shown to acquire gradually incre
115 tamase (NDM)-producing Escherichia coli in a bacteremic patient with sequential failure of aztreonam
116 ical decision tree can be used to estimate a bacteremic patient's likelihood of infection with ESBL-p
117  greater for CP-CRE compared with non-CP-CRE bacteremic patients (adjusted odds ratio, 4.92; 95% conf
118 as the exposure variable, in the subgroup of bacteremic patients (n = 207) and in the propensity-matc
119 itional methods for identifying pathogens in bacteremic patients are slow (24-48+ h).
120                             Five (32%) of 16 bacteremic patients died vs. none of the 95 control pati
121 isolates and the clinical characteristics of bacteremic patients enrolled in a phase III trial of S.
122 occal and enterococcal strains isolated from bacteremic patients expressed proteins that comigrated w
123 rty-seven unique MRSA isolates obtained from bacteremic patients in multicenter prospective clinical
124 ck were compared with a cohort of 376 purely bacteremic patients in septic shock.
125 sent a viable adjuvant therapy for septic or bacteremic patients in the intensive care unit.
126           Among isolates from PP, those from bacteremic patients overexpressed nonsignificantly more
127 mmonly used antibiotics for the treatment of bacteremic patients throughout the 1970s were amoxicilli
128                                              Bacteremic patients were more likely to have benign pros
129 omorbid medical conditions were evaluated in bacteremic patients who demonstrated BEE and in those wh
130                                   Among MSSA-bacteremic patients who did not die or get hospitalized
131        Septic shock was identified in 43% of bacteremic patients with type 3 secretion system+ isolat
132                                        Of 25 bacteremic patients, 14 (10 with gram-positive bacteremi
133 l studies and to reduce clinical severity in bacteremic patients.
134  was significantly increased in the serum of bacteremic patients.
135 re more frequent in the urinary strains from bacteremic patients.
136 illing of S. aureus were detected in 9 of 15 bacteremic patients.
137 or agr are associated with worse outcomes in bacteremic patients.
138  rates (per 1000 person-years) were 0.21 for bacteremic pneumococcal CAP (0.14 vs 0.26 among vaccinat
139 rs ago) was associated with reduced risks of bacteremic pneumococcal CAP (hazard ratio [HR], 0.38; 95
140  urine antigen test was positive in 51 of 58 bacteremic pneumococcal cases (sensitivity, 88%; 95% con
141 alveoli, thereby protecting the host against bacteremic pneumococcal disease.
142  survival among critically ill patients with bacteremic pneumococcal illness.
143 e, and rapid test for the early diagnosis of bacteremic pneumococcal infections in adult patients, ev
144 ochromatographic assay, for the diagnosis of bacteremic pneumococcal infections in hospitalized adult
145 eumoniae urine antigen test in patients with bacteremic pneumococcal infections.
146 h active surveillance, all culture-confirmed bacteremic pneumococcal pneumonia (BPP) among adults in
147  admission from 14 (27%) of 51 patients with bacteremic pneumococcal pneumonia and 11 (37%) of 30 wit
148 ried significantly by clinical presentation: bacteremic pneumococcal pneumonia incidence peaked in la
149 at combination antibiotic therapy for severe bacteremic pneumococcal pneumonia may reduce mortality.
150  anti-pneumolysin IgG than did patients with bacteremic pneumococcal pneumonia or uninfected control
151                                     CAAP and bacteremic pneumococcal pneumonia were strongly reduced
152 during 2022 from a 66-year-old resident with bacteremic pneumococcal pneumonia within a Centers for D
153 es, the most frequent clinical phenotype was bacteremic pneumonia (69%), with meningitis accounting f
154 was associated with significant increases in bacteremic pneumonia cases (attributable percentage, 15.
155 5BC, 16F, and 23B) were rarely isolated from bacteremic pneumonia cases and were particularly involve
156 in IPD type was mostly due to a reduction in bacteremic pneumonia frequency (from 42.1% to 19.1%; P <
157                                    Using our bacteremic pneumonia model we further investigated the e
158                                         In a bacteremic pneumonia model, we observed a PcpA-dependent
159 esentation among those aged <1 year (71.4%); bacteremic pneumonia was the most common presentation am
160 cal presentation among <1 year olds (71.4%); bacteremic pneumonia was the most common presentation am
161  lower respiratory tract infections (V-LRI), bacteremic pneumonia, nonbacteremic pneumonia and nonpne
162  as any possible complication of meningitis, bacteremic pneumonia, or bacteremia (including hearing l
163  as any possible complication of meningitis, bacteremic pneumonia, or bacteremia (including hearing l
164 cantly during convalescence in patients with bacteremic pneumonia, reaching levels observed in nonbac
165 uce all IPD clinical presentations including bacteremic pneumonia.
166 on among adults is typically associated with bacteremic pneumonia.
167 e cell recruitment to the lung tissue during bacteremic pneumonia.
168 ons (31.4%; 95% CI, 8.8%-51.4%) but not with bacteremic pneumonia.
169 2% and 95.9% against a reference standard of bacteremic pneumonia.
170 n-tazobactam (TZP) for the management of non-bacteremic pyelonephritis caused by ESBL-producing organ
171 solated from the blood and nasal passages of bacteremic rats to colonize the nasopharynx and invade t
172                                              Bacteremic relapse was similar between the two groups (1
173 mbination therapy on duration of bacteremia, bacteremic relapse, and acute kidney injury (AKI).
174              We established a mouse model of bacteremic S. aureus infection to correlate bacteriologi
175 cquired pneumonia, cure rates for those with bacteremic S. aureus pneumonia were 41% (9/22, telavanci
176  the liver during normotensive gram-negative bacteremic sepsis alters the kinetics of circulating end
177  mg/kg) markedly improved survival in lethal bacteremic sepsis and aspiration pneumonia models of XDR
178 SI, moderate-to-poor discrimination for both bacteremic sepsis and occult BSI and did not appear to m
179 .5, or 25 microg x kg-1 x hr-1 ) 3 hrs after bacteremic sepsis maintained a normal mean arterial pres
180 led Escherichia coli (1 x 10(9) CFU/kg), and bacteremic sepsis was induced 12 h later by infusion of
181 quential Organ Failure Assessment quartiles, bacteremic sepsis, and ICU admission.
182 nflammation early after normotensive E. coli bacteremic sepsis.
183 as 60% in candidemic septic shock and 46% in bacteremic septic shock (p =.38).
184 tion II: candidemic septic shock, 32 +/- 10; bacteremic septic shock, 30 +/- 8; p =.44).
185 le organ failure compared with patients with bacteremic septic shock.
186 standardized order set for the management of bacteremic severe sepsis was associated with greater flu
187 standardized order set for the management of bacteremic severe sepsis.
188  82% males), 23 had nonbacteremic and 10 had bacteremic severe tularemia.
189 cid metabolite release in a porcine model of bacteremic shock and b) selectively block PAF, thromboxa
190 lar O2 tension commonly follow gram-negative bacteremic shock that progresses to the acute respirator
191 come, primarily in models of endotoxemic and bacteremic shock.
192 ations to cause the pulmonary derangement of bacteremic shock.
193 d cardiopulmonary dysfunction, as well as of bacteremic shock.
194 htly improved bacterial clearance during the bacteremic stage compared with controls.
195 de that inhibition of C5 cleavage during the bacteremic stage of sepsis could be an important therape
196 tment, we could potentially influence future bacteremic states.
197 atment we could potentially influence future bacteremic states.
198 fferent bacterial species recovered from 151 bacteremic subjects.
199 me, adolescents and young adults who develop bacteremic symptoms should be aggressively treated with
200 ths old were significantly less likely to be bacteremic than cats <or=6 months old (odds ratio = 0.18
201 strains were isolated were more likely to be bacteremic than were patients with other A. baumannii is
202                                              Bacteremic trauma victims have a higher risk of death th
203  Charlson comorbidity index predicted severe bacteremic tularemia (odds ratio, 2.7 per score-point; 9
204  by hospitalization for >24 hours and severe bacteremic tularemia by Francisella tularensis subsp.
205 .0 hours in nonbacteremic and 115.0 hours in bacteremic tularemia.
206               All cats remained persistently bacteremic until they were treated 4 to 7 weeks after pr
207 igible participants were adult patients with bacteremic urinary tract infections due to MDR E coli; 1
208 P surgery, only 25% of C10-treated mice were bacteremic versus 85% of the control group that exhibite
209       At 24 h, 21 of 27 Mac-1(-/-) mice were bacteremic, vs 15 of 25 WT (p = 0.05); no difference was
210                     One kitten that remained bacteremic was treated unsuccessfully with enrofloxacin,
211                                      No cats bacteremic with B. clarridgeiae were found.
212                                         Cats bacteremic with B. henselae constitute a large reservoir
213 alifornia, 31 animals (28%) were found to be bacteremic with B. vinsonii subsp. berkhoffii and 83 ani
214 in women than in men; it was also found that bacteremic women were more likely to be infected with HI

 
Page Top